Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on OncoSil Medical.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Health Check: The Winner Takes It All as US investors back advanced biotech plays
Health & Biotech
MoneyTalks: Pengana’s James McDonald reveals his top three ASX biotechs
Health & Biotech
Alive and Kicking: Respiri promises breath of life to bottom line after inking US distribution deal
News
Closing Bell: Origin, Cochlear dive on earnings; RBA rate cut looks less likely after jobs report
Health & Biotech
ASX Health Stocks: PYC to start trials for rare eye disease; OncoSil device successful in tumour removal
Health & Biotech
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month
News
ASX July Winners: The best 50 stocks in a strong month for markets
Health & Biotech
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
News
Market Highlights: Wall Street in a sea of red, and cannabis stocks in focus after US report
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX tumbles on Fedspeak; gold and oil jump as Middle East tension escalates
News
Market Highlights: Big Tech rebounds sharply, Costco in the gold game, and 5 small caps to watch today
News
ASX Small Caps and IPO Weekly Wrap: A short week for a small win on the ASX
News
Closing Bell: Tech leads ASX selloff; sluggish iron ore, gold prices also weigh on miners
News
Top 10 at 10: Big bagging health stocks and some impressive (unstimulated) gas flow
News
